![Sun Pharma Q2 FY24 Results: Consolidated PAT Rises to Rs. 2375.51 Cr Sun Pharma Q2 FY24 Results: Consolidated PAT Rises to Rs. 2375.51 Cr](https://www.sharemarketexpress.com/wp-content/uploads/2023/10/500x300_197182-sun-pharma-4-1-1-600x400.jpg)
Sun Pharma Q2 FY24 Results: Consolidated PAT Rises to Rs. 2375.51 Cr
Sun Pharma Q2 FY24 Results Today Sun Pharma Q2 results show revenue up from 12,145.28 crores to 12,486.02 crores, a…
Sun Pharma Q2 FY24 Results Today Sun Pharma Q2 results show revenue up from 12,145.28 crores to 12,486.02 crores, a…
Sun Pharma, Aurobindo recall US market drugs Leading pharmaceutical companies Sun Pharmaceutical Industries and Aurobindo Pharma have initiated recalls of…
Sun Pharmaceutical Industries Ltd, a leading drug manufacturer, announced a significant milestone on Friday as the United States Food and…
In a strategic stake acquisition move, pharmaceutical powerhouse Sun Pharma has announced its acquisition of a substantial 37.76% stake in…
Sun Pharmaceutical Industries Ltd has announced its plans to acquire Indi Pharma’s stake in its Mexican unit. The pharmaceutical giant…
Sun Pharma Q1 results show revenue up from 11303.95 crores to 12145.28 crores, a 6.93% increase in growth. EPS rise…
Results scheduled for 29th May Prior to the release of quarterly earnings on May 25, attention will be focused on…
Sun Pharmaceutical Limited Q4 results show revenue fell from 11414.85 to 11303.95 crores, a 0.97% decrease in growth. EPS also…